Finance

Results: 25201-25212 of 35675

Study Suggests Critical Link Between Residual FLT3-ITD Mutations in Remission and Post-Transplant Outcomes in AML

PR Newswire associated0

LyondellBasell Weighs Strategic Options for European Assets

The third Tashkent International Investment Forum showcases Uzbekistan's investment potential after $26.6 billion in agreements successfully signed

Valmet chosen as the third most attractive employer by engineering students in Finland

Implantica presents the first quarter 2024 on May 15 at 15:00 CEST

ACCESSWIRE associated0

AGFA HealthCare Demonstrates How Enterprise Imaging Enables 'Imaging Without Barriers' at UKIO 2024

PR Newswire associated0

NEOM announces Jaumur, a cosmopolitan marina community

Tigo Energy Delivers Most Powerful Solar MLPE for High-Wattage and Bifacial Modules

PR Newswire associated0

New Momentum in Pharma Automation: ArisGlobal's 2024 Industry Survey Report Highlights Surge in AI-Powered Safety & Regulatory Processes

PR Newswire associated0

A Connected and Sustainable Energy World - 17th Singapore International Energy Week

Greenland Resources Submits Updated Social Impact Assessment

Biotechnology scientist and entrepreneur and Kindeva Drug Delivery’s Head of the Scientific Advisory Board, John Patton (second from the left), was named the winner of the Charles G. Thiel Award for outstanding research and discovery in respiratory drug delivery at this year’s Respiratory Drug Delivery (RDD) Conference. Also pictured (from left to right): Michael Hindle, Ph.D., Professor, School of Pharmacy at Virginia Commonwealth University, Stephen Stein, Scientific Director of Inhalation Product Development at Kindeva, and Milton Boyer, CEO at Kindeva. (Photo: Business Wire)

John Patton, Head of Kindeva Drug Delivery’s Scientific Advisory Board, Named Winner of RDD Conference’s Charles G. Thiel Award